Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canvaxin for In-Transit Melanoma
NCT00128583Phase 2Unknown
- Sponsor
- CancerVax
- Start
- Jul 2005
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of CANVAXIN in cutaneous melanoma (CM), sponsored by CancerVax. Status: unknown.
02
Drugs
CANVAXIN
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT00128583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128583.